Indirect effectiveness of a novel SARS-COV-2 vaccine (SCB-2019) in unvaccinated household contacts in the Philippines: a cluster randomised analysis

Background - Though observational evidence supports indirect effects of SARS-CoV-2 vaccines, randomised experiments are lacking. To address this gap, the double-blinded, prospective follow-up of the household contacts (HHCs) of Philippine participants of the individually-randomised, placebo-controll...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Aziz, Asma Binte (VerfasserIn) , Sugimoto, Jonathan Dewing (VerfasserIn) , Hong, Sye Lim (VerfasserIn) , You, Young Ae (VerfasserIn) , Bravo, Lulu (VerfasserIn) , Roa, Camilo (VerfasserIn) , Borja-Tabora, Charissa (VerfasserIn) , Montellano, May Emmeline B. (VerfasserIn) , Carlos, Josefina (VerfasserIn) , Los Reyes, Mari Rose A. de (VerfasserIn) , Alberto, Edison R. (VerfasserIn) , Salvani-Bautista, Milagros (VerfasserIn) , Kim, Hwa Young (VerfasserIn) , Njau, Irene (VerfasserIn) , Clemens, Ralf (VerfasserIn) , Marks, Florian (VerfasserIn) , Tadesse, Birkneh Tilahun (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: October 2024
In: Journal of infection
Year: 2024, Jahrgang: 89, Heft: 4, Pages: [1]-12
ISSN:1532-2742
DOI:10.1016/j.jinf.2024.106260
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.jinf.2024.106260
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0163445324001944
Volltext
Verfasserangaben:Asma Binte Aziz, Jonathan Dewing Sugimoto, Sye Lim Hong, Young Ae You, Lulu Bravo, Camilo Roa, Charissa Borja-Tabora, May Emmeline B. Montellano, Josefina Carlos, Mari Rose A. de Los Reyes, Edison R. Alberto, Milagros Salvani-Bautista, Hwa Young Kim, Irene Njau, Ralf Clemens, Florian Marks, Birkneh Tilahun Tadesse

MARC

LEADER 00000caa a2200000 c 4500
001 1923460692
003 DE-627
005 20250717011055.0
007 cr uuu---uuuuu
008 250423s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jinf.2024.106260  |2 doi 
035 |a (DE-627)1923460692 
035 |a (DE-599)KXP1923460692 
035 |a (OCoLC)1528044816 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Aziz, Asma Binte  |e VerfasserIn  |0 (DE-588)1363785400  |0 (DE-627)1923461028  |4 aut 
245 1 0 |a Indirect effectiveness of a novel SARS-COV-2 vaccine (SCB-2019) in unvaccinated household contacts in the Philippines  |b a cluster randomised analysis  |c Asma Binte Aziz, Jonathan Dewing Sugimoto, Sye Lim Hong, Young Ae You, Lulu Bravo, Camilo Roa, Charissa Borja-Tabora, May Emmeline B. Montellano, Josefina Carlos, Mari Rose A. de Los Reyes, Edison R. Alberto, Milagros Salvani-Bautista, Hwa Young Kim, Irene Njau, Ralf Clemens, Florian Marks, Birkneh Tilahun Tadesse 
264 1 |c October 2024 
300 |b Diagramme 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.04.2025 
520 |a Background - Though observational evidence supports indirect effects of SARS-CoV-2 vaccines, randomised experiments are lacking. To address this gap, the double-blinded, prospective follow-up of the household contacts (HHCs) of Philippine participants of the individually-randomised, placebo-controlled trial of the adjuvanted-subunit protein COVID-19 vaccine, SCB-2019, (EudraCT, 2020-004272-17; ClinicalTrials.gov, NCT04672395) was analyzed in a cluster-randomised fashion. - Methods - Over an eight-week period, HHCs were followed by rRT-PCR and paired rapid antibody tests (RATs) to detect symptomatic (SCI, primary) and all (ACI, secondary) SARS-CoV-2 infection. A standard analysis estimated the indirect effectiveness of SCB-2019 for each endpoint, excluding HHC RAT-positive at enrollment. A secondary analysis employed enzyme-linked immunosorbent assay (ELISA) results to correct for suspected bias. - Findings - SCB-2019 (N = 3470) and placebo (N = 3225) exposed HHCs contributed to at least one analysis. The standard analysis estimated that SCB-2019 reduced the risk of SCI by 83% (95% confidence/credible interval [CI: 32% to 96%), with no effect against ACI. The bias-corrected relative risk reduction was 97% (95% CI: 74% to 100%) for SCI and 79% (95% CI: 14% to 96%) for ACI, with an estimated one SARS-CoV-2 infection prevented per 4.8 households where one member received SCB-2019. - Interpretation - SCB-2019 demonstrated bias-corrected indirect effectiveness against SARS-CoV-2 infection among HHC, even at a modest coverage level in the household (approximately 25%). Further research into the indirect effects of SARS-CoV-2 vaccines is needed to optimize the impact of limited doses in low and middle-income settings. 
650 4 |a Household contacts 
650 4 |a Indirect effectiveness 
650 4 |a SCB-2019, SARS-CoV-2 vaccine 
700 1 |a Sugimoto, Jonathan Dewing  |e VerfasserIn  |4 aut 
700 1 |a Hong, Sye Lim  |e VerfasserIn  |4 aut 
700 1 |a You, Young Ae  |e VerfasserIn  |4 aut 
700 1 |a Bravo, Lulu  |e VerfasserIn  |4 aut 
700 1 |a Roa, Camilo  |e VerfasserIn  |4 aut 
700 1 |a Borja-Tabora, Charissa  |e VerfasserIn  |4 aut 
700 1 |a Montellano, May Emmeline B.  |e VerfasserIn  |4 aut 
700 1 |a Carlos, Josefina  |e VerfasserIn  |4 aut 
700 1 |a Los Reyes, Mari Rose A. de  |e VerfasserIn  |4 aut 
700 1 |a Alberto, Edison R.  |e VerfasserIn  |4 aut 
700 1 |a Salvani-Bautista, Milagros  |e VerfasserIn  |4 aut 
700 1 |a Kim, Hwa Young  |e VerfasserIn  |4 aut 
700 1 |a Njau, Irene  |e VerfasserIn  |4 aut 
700 1 |a Clemens, Ralf  |e VerfasserIn  |4 aut 
700 1 |a Marks, Florian  |d 1975-  |e VerfasserIn  |0 (DE-588)130584258  |0 (DE-627)504163736  |0 (DE-576)298281589  |4 aut 
700 1 |a Tadesse, Birkneh Tilahun  |e VerfasserIn  |0 (DE-588)1328708160  |0 (DE-627)1888121114  |4 aut 
773 0 8 |i Enthalten in  |t Journal of infection  |d Amsterdam [u.a.] : Elsevier, 1979  |g 89(2024), 4, Artikel-ID 106260, Seite [1]-12  |h Online-Ressource  |w (DE-627)320506436  |w (DE-600)2012883-6  |w (DE-576)104344717  |x 1532-2742  |7 nnas  |a Indirect effectiveness of a novel SARS-COV-2 vaccine (SCB-2019) in unvaccinated household contacts in the Philippines a cluster randomised analysis 
773 1 8 |g volume:89  |g year:2024  |g number:4  |g elocationid:106260  |g pages:[1]-12  |g extent:12  |a Indirect effectiveness of a novel SARS-COV-2 vaccine (SCB-2019) in unvaccinated household contacts in the Philippines a cluster randomised analysis 
856 4 0 |u https://doi.org/10.1016/j.jinf.2024.106260  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0163445324001944  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250423 
993 |a Article 
994 |a 2024 
998 |g 130584258  |a Marks, Florian  |m 130584258:Marks, Florian  |d 910000  |d 912800  |e 910000PM130584258  |e 912800PM130584258  |k 0/910000/  |k 1/910000/912800/  |p 15 
999 |a KXP-PPN1923460692  |e 4708498578 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"October 2024","dateIssuedKey":"2024"}],"note":["Gesehen am 23.04.2025"],"recId":"1923460692","language":["eng"],"name":{"displayForm":["Asma Binte Aziz, Jonathan Dewing Sugimoto, Sye Lim Hong, Young Ae You, Lulu Bravo, Camilo Roa, Charissa Borja-Tabora, May Emmeline B. Montellano, Josefina Carlos, Mari Rose A. de Los Reyes, Edison R. Alberto, Milagros Salvani-Bautista, Hwa Young Kim, Irene Njau, Ralf Clemens, Florian Marks, Birkneh Tilahun Tadesse"]},"person":[{"family":"Aziz","display":"Aziz, Asma Binte","role":"aut","given":"Asma Binte"},{"role":"aut","given":"Jonathan Dewing","family":"Sugimoto","display":"Sugimoto, Jonathan Dewing"},{"display":"Hong, Sye Lim","family":"Hong","given":"Sye Lim","role":"aut"},{"role":"aut","given":"Young Ae","family":"You","display":"You, Young Ae"},{"given":"Lulu","role":"aut","display":"Bravo, Lulu","family":"Bravo"},{"role":"aut","given":"Camilo","family":"Roa","display":"Roa, Camilo"},{"given":"Charissa","role":"aut","display":"Borja-Tabora, Charissa","family":"Borja-Tabora"},{"family":"Montellano","display":"Montellano, May Emmeline B.","role":"aut","given":"May Emmeline B."},{"family":"Carlos","display":"Carlos, Josefina","role":"aut","given":"Josefina"},{"given":"Mari Rose A. de","role":"aut","display":"Los Reyes, Mari Rose A. de","family":"Los Reyes"},{"family":"Alberto","display":"Alberto, Edison R.","role":"aut","given":"Edison R."},{"display":"Salvani-Bautista, Milagros","family":"Salvani-Bautista","given":"Milagros","role":"aut"},{"family":"Kim","display":"Kim, Hwa Young","role":"aut","given":"Hwa Young"},{"given":"Irene","role":"aut","display":"Njau, Irene","family":"Njau"},{"role":"aut","given":"Ralf","family":"Clemens","display":"Clemens, Ralf"},{"family":"Marks","display":"Marks, Florian","role":"aut","given":"Florian"},{"family":"Tadesse","display":"Tadesse, Birkneh Tilahun","role":"aut","given":"Birkneh Tilahun"}],"relHost":[{"disp":"Indirect effectiveness of a novel SARS-COV-2 vaccine (SCB-2019) in unvaccinated household contacts in the Philippines a cluster randomised analysisJournal of infection","origin":[{"publisherPlace":"Amsterdam [u.a.] ; London [u.a.]","dateIssuedDisp":"1979-","publisher":"Elsevier ; Harcourt","dateIssuedKey":"1979"}],"note":["Gesehen am 04.09.2025"],"part":{"pages":"[1]-12","issue":"4","extent":"12","volume":"89","year":"2024","text":"89(2024), 4, Artikel-ID 106260, Seite [1]-12"},"language":["eng"],"recId":"320506436","type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title":"Journal of infection","title_sort":"Journal of infection"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1532-2742"],"eki":["320506436"],"zdb":["2012883-6"]},"pubHistory":["1.1979 -"]}],"title":[{"subtitle":"a cluster randomised analysis","title_sort":"Indirect effectiveness of a novel SARS-COV-2 vaccine (SCB-2019) in unvaccinated household contacts in the Philippines","title":"Indirect effectiveness of a novel SARS-COV-2 vaccine (SCB-2019) in unvaccinated household contacts in the Philippines"}],"physDesc":[{"noteIll":"Diagramme","extent":"12 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1016/j.jinf.2024.106260"],"eki":["1923460692"]}} 
SRT |a AZIZASMABIINDIRECTEF2024